Fig. 2From: Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling studyPercentage of deaths averted for targeted interventions for A Kenya, BÂ Mexico, CÂ United States and DÂ Belgium. Percentage of deaths averted assuming an epidemic wave with parameters similar to those of the Omicron epidemic wave (transmissibility, vaccine effectiveness, and vaccination coverage) when compared to a baseline of no antiviral treatment using antiviral treatment in targeted age groups. For each country, the colors represent four possible values of AVT (25, 50, 75 or 100% reduction in viral transmission in treated symptomatic individuals) and targeting the antiviral treatment to symptomatic adults older than 18, 30, 50 or 65 years of age with a daily treatment initiation rate of 20%Back to article page